Literature DB >> 16790383

Ventricular assist device-related infections.

Rachel J Gordon1, Bianca Quagliarello, Franklin D Lowy.   

Abstract

Heart failure is a leading cause of death in developed nations despite medical management. Cardiac transplantation is a potentially lifesaving intervention for approximately 4000 advanced heart failure patients per year; however, the demand for donor hearts far exceeds the supply. Ventricular assist devices provide temporary support for patients with severe heart failure until myocardial recovery occurs or a donor heart becomes available. For those ineligible for transplantation, ventricular assist devices may be used permanently and have demonstrated reduced mortality and an improved quality of life compared with continued medical therapy. Nonetheless, these devices are under-used, in part due to the frequency of complications. Device-related infections are one of the most frequent sequelae of ventricular assist device placement and occur in 18-59% of cases. Infections can involve any part of the device and confer substantial morbidity and mortality. Here, we provide an introduction to ventricular assist devices, explore the nature and pathogenesis of ventricular assist device-related infections, discuss problems with diagnosis, and present treatment and prevention strategies.

Entities:  

Mesh:

Year:  2006        PMID: 16790383     DOI: 10.1016/S1473-3099(06)70522-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  35 in total

Review 1.  The use of computational fluid dynamics in the development of ventricular assist devices.

Authors:  Katharine H Fraser; M Ertan Taskin; Bartley P Griffith; Zhongjun J Wu
Journal:  Med Eng Phys       Date:  2010-11-13       Impact factor: 2.242

Review 2.  Mouse models for infectious diseases caused by Staphylococcus aureus.

Authors:  Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  J Immunol Methods       Date:  2014-04-24       Impact factor: 2.303

3.  Cardiovascular implantable device infections.

Authors:  George M Viola; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

Review 4.  Interfacial tissue engineering of heart regenerative medicine based on soft cell-porous scaffolds.

Authors:  Xiwen Geng; Bing Liu; Jiaqing Liu; Dong Liu; Yupeng Lu; Xiaotian Sun; Kang Liang; Biao Kong
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 5.  Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds?

Authors:  Maribella Domenech; Lilliana Polo-Corrales; Jaime E Ramirez-Vick; Donald O Freytes
Journal:  Tissue Eng Part B Rev       Date:  2016-07-21       Impact factor: 6.389

6.  Managing drugs and devices in patients with permanent ventricular assist devices.

Authors:  Martin Cadeiras; Manuel von Bayern; Mario C Deng
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

7.  The role of ionic interactions in the adherence of the Staphylococcus epidermidis adhesin SdrF to prosthetic material.

Authors:  Faustino A Toba; Livia Visai; Sheetal Trivedi; Franklin D Lowy
Journal:  FEMS Microbiol Lett       Date:  2012-11-02       Impact factor: 2.742

8.  Prospective, multicenter study of ventricular assist device infections.

Authors:  Rachel J Gordon; Alan D Weinberg; Francis D Pagani; Mark S Slaughter; Pat S Pappas; Yoshifumi Naka; Daniel J Goldstein; Walter P Dembitsky; Julie C Giacalone; Jennifer Ferrante; Deborah D Ascheim; Alan J Moskowitz; Eric A Rose; Annetine C Gelijns; Franklin D Lowy
Journal:  Circulation       Date:  2013-01-11       Impact factor: 29.690

Review 9.  Endocarditis in left ventricular assist device.

Authors:  Braghadheeswar Thyagarajan; Monisha Priyadarshini Kumar; Rutuja R Sikachi; Abhinav Agrawal
Journal:  Intractable Rare Dis Res       Date:  2016-08

10.  SdrF, a Staphylococcus epidermidis surface protein, contributes to the initiation of ventricular assist device driveline-related infections.

Authors:  Carlos Arrecubieta; Faustino A Toba; Manuel von Bayern; Hirokazu Akashi; Mario C Deng; Yoshifumi Naka; Franklin D Lowy
Journal:  PLoS Pathog       Date:  2009-05-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.